StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-2.91%)

Close on Nov 17, 2026Market cap $383.64KP/E –Yield –

VivoSim Labs enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

VivoSim Labs's enterprise value was -$1.18M on Nov 11, 2026, against -$835.17K a year earlier. Over the last 5 years it ranged from -$13.26M to $9.98M, with a median of -$739.18K.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$1.18M–
2025Dec 31, 2025-$1.96M-150.3%
2024Dec 31, 2024$3.89M+88.8%
2023Dec 29, 2023$2.06M–
2022Dec 30, 2022-$10.93M–
2021Dec 31, 2021-$2.19M-103.4%
2020Dec 31, 2020$65.15M+292.3%
2019Dec 31, 2019$16.61M-77.3%
2018Dec 31, 2018$73.24M-20.8%
2017Dec 29, 2017$92.53M-65.2%
2016Dec 30, 2016$266.11M+73.9%
2015Dec 31, 2015$153.03M-71.0%
2014Dec 31, 2014$528.54M-16.5%
2013Dec 31, 2013$633.17M+1149.3%
2012Dec 31, 2012$50.68M–

More VivoSim Labs figures

See a number that looks wrong?